Mizuho Senior Biotech Analyst Salim Syed highlights key companies in the news he covers heading into the new year
BiotechTV - News
00:00
Truvy launch and market share
Salim compares Bridge's oral Truvy to Alnylam, forecasting sizable uptake and multibillion-dollar potential.
Play episode from 03:03
Transcript
